AimTop Ventures

Artly Coffee, founded in 2020 and based in Seattle, Washington, operates hybrid coffee stores that feature a robot barista. This innovative approach combines artificial intelligence and computer vision to create specialty coffee. The robot barista learns various coffee-making techniques from expert human baristas, ensuring high-quality beverages. Customers can customize and place their orders through an application, which the robots process, thereby reducing the risks associated with human contact and enhancing public health safety. Artly Coffee's unique blend of technology and coffee craftsmanship sets it apart in the specialty coffee market.

Phyla Therapeutics, Inc. specializes in developing microbiome-based therapeutics aimed at treating chronic skin diseases. Founded in 2014 and headquartered in San Francisco, the company focuses on innovative approaches to healthcare by utilizing bacteriophages to selectively eliminate harmful bacteria while preserving beneficial strains within the microbiome. This subtractive method provides an alternative to traditional antibiotics, which often indiscriminately kill both good and bad bacteria. By promoting a balanced microbiome, Phyla aims to enhance skin health and address conditions like acne through its proprietary microbiome editor, a biologic product that targets acne-causing bacteria while fostering the growth of positive skin flora.

TriagingX is located in Silicon Valley. Their team successfully built the first generation malware sandbox that has been used by many fortune 500 companies for daily malware analysis. They are now building the next generation sandbox and a larger scale advanced analytic system, on a public and a private cloud, that takes malware sandbox behavior outputs, endpoint snapshots, network logs, and outputs from other security products (IDS/IPS, FW, etc.), to provide the most comprehensive analysis for advanced attacks. Their mission is to work closely with their clients to help them always stay ahead of the attacker and to find and fix weaknesses in their networks before any actual attack happens.

Atomwise, Inc. specializes in deep learning artificial intelligence technology aimed at small molecule drug discovery. The company leverages its proprietary AI platform, AtomNet, which contains over 16 billion molecules for virtual screening, to enhance the speed and accuracy of drug discovery processes. This technology employs a statistical approach to predict the binding of small molecules to proteins, aiding in drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise collaborates on numerous projects each year with major pharmaceutical and agrochemical companies, as well as over 200 universities and hospitals across 40 countries. Founded in 2012 and based in San Francisco, Atomwise was previously known as Chematria, Inc. before rebranding in 2015.

Oculii is an advanced radar sensor developer specializing in 4D radar design and fusion. 4D sensors have traditionally been the domain of high power, expensive military grade radar or laser systems. Backed by top-tier Silicon Valley angel investors and VCs - they've turned this paradigm on its head, leveraging advanced sensor fusion techniques to manufacture smarter, high precision sensors and systems. Their technology allows us to extract unprecedented accuracy, range, and 4D positioning information from commodity off the shelf low-cost radar elements, bringing high resolution radar imaging to the next frontier.

Magnetic Insight, Inc. specializes in magnetic particle imaging (MPI), a novel imaging modality that detects iron oxide nanoparticle tracers using time-varying magnetic fields. The company has developed several key products, including the MOMENTUM imager, a pre-clinical MPI solution that produces detailed images through advanced reconstruction techniques, and VivoTrax, a nanoparticle designed for cell tracking and as a blood pool agent in pre-clinical studies. Additionally, the company offers Hyper, a module for localized magnetic hyperthermia, and Relax, which focuses on particle relaxometry. Founded in 2012 and based in Alameda, California, Magnetic Insight is dedicated to enhancing preclinical diagnostics and research by enabling quantitative cell tracking, imaging vascular functions, and detecting metastatic tumors, thereby addressing significant challenges in clinical and translational research.

NEXT Trucking is a technology platform connecting shippers with owner/operators and small fleets. It is building smart technology that matches truck drivers to their preferred loads, addressing the problem of carrier capacity. The company combines a freight marketplace with over 16,000 drivers, company-owned assets, and strategic partnerships to provide customers with an unrivaled suite of services from OTR to drayage and warehousing. NEXT Trucking was founded in 2015 and is based in Lynwood, California.

CloudMedx Inc. is a software development company based in Palo Alto, California, that specializes in artificial intelligence solutions for the healthcare sector. Founded in 2014, the company focuses on extracting key clinical concepts from electronic health records to provide actionable insights that enhance clinical operations, documentation, and patient care. Its platform transforms disparate healthcare data into a cohesive view that supports better clinical, treatment, and diagnostic outcomes. By integrating with existing systems, CloudMedx aims to facilitate collaboration among healthcare providers, payers, and patients. The company offers tools for patient engagement, risk stratification, and timely notifications for care needs, serving a diverse clientele that includes managed care organizations, accountable care organizations, and various healthcare facilities. The mission of CloudMedx is driven by a commitment to improve healthcare delivery, stemming from personal experiences related to misdiagnosis and the inefficiencies within the healthcare system.